Tim Patrick Kaminski

Tim Patrick Kaminski is a seasoned executive in the scientific field, currently serving as Chief Scientific Officer and CEO at InSingulo AB since October 2017. Prior to this role, Tim contributed to AstraZeneca as a Post Doc from October 2014 to September 2017. Tim's academic journey includes a Ph.D. from the University of Bonn, where major focus areas involved cancer cell chemotaxis and molecular biology. Tim has also held research assistant positions, notably developing software for workflow efficiency and conducting laboratory work on receptor interactions and signaling. Tim earned a Diplom in Biological Sciences from the University of Bonn in 2008.